TME Pharma N.V. (0N6A.F)
TME Pharma N.V., a clinical-stage biopharmaceutical company, focuses on the development of proprietary therapeutics for the treatment of cancer in Germany.
0.06+0.01%Healthcare
StockGlow Score
Bearish
BearishBullish
1 year ago-44.7%
The outlook
TME Pharma N.V. currently reads as bearish based on below its 50- & 200-day averages, 25% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range25% of the way from its 52-week low to high
Market cap
$5.4M
52-wk high
0.13
52-wk low
0.03
50-day avg
0.07
200-day avg
0.07
Trailing P/E
—